Neuroimaging-based biomarkers in psychiatry: Clinical opportunities of a paradigm shift

Canadian Journal of Psychiatry

Volumn 58, Issue 9, 2013, Pages 499-508

  Fu, Cynthia H Y ^a   Costafreda, Sergi G ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Queen Mary University of London and Barts NIHR BRC NHS Trust National Institute for Health and Care Research   (United Kingdom)

Author keywords

Alzheimer; Biomarkers; Depression; Machine learning; Magnetic resonance imaging; Neuroimaging; Personalized; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; AUTISM; BRAIN DISEASE; BRAIN FUNCTION; BRAIN MAPPING; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COGNITIVE THERAPY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; EARLY DIAGNOSIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HEALTH SURVEY; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MACHINE LEARNING; MAJOR DEPRESSION; MEDICAL EXPERT; MENTAL DISEASE; MENTAL PATIENT; MILD COGNITIVE IMPAIRMENT; MULTIVARIATE ANALYSIS; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PREDICTIVE VALUE; PROFESSIONAL KNOWLEDGE; PROGNOSIS; PSYCHIATRY; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; WHITE MATTER; WORKING MEMORY;

EID: 84884482813     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371305800904     Document Type: Review

References (83)

1. Biomarkers Definitions Working Group NIH. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95.
2. Kraemer HC, Kupfer DJ, Clarke DE, et al. DSM-5: How reliable is reliable enough? Am J Psychiatry. 2012;169(1):13-15.
3. Kupfer DJ, First MB, Regier DA, editors. Neuroscience research agenda to guide development of a pathophysiologically based classification system. A research agenda for DSM-V. Washington (DC): American Psychiatric Press; 2002.
4. Insel T, Cuthbert B, Garvey M, et al. Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748-751.
5. Clarke R, Ressom HW, Wang A, et al. The properties of highdimensional data spaces: Implications for exploring gene and protein expression data. Nat Rev Cancer. 2008;8(1):37-49.
6. Duin RPW. Classifiers in almost empty spaces. 15th International Conference on Pattern Recognition; Barcelona, Spain; September 3-7, 2000. p 1-7.
7. Noble WS. What is a support vector machine? Nat Biotechnol. 2006;24(12):1565-1567.
8. Mitchell TM. The discipline of machine learning. Technical report. Pittsburgh (PA): Carnegie Mellon University, School of Computer Science, Machine Learning Department; 2006. Contract number CMU-ML-06-108.
9. Pereira F, Mitchell T, Botvinick M. Machine learning classifiers and fMRI: A tutorial overview. Neuroimage. 2009;45(1 Suppl 1):S199-S209.
10. Costafreda SG. Pooling fMRI data: Meta-Analysis, mega-Analysis and multi-Center studies. Front Neuroinform. 2009;3:33.
11. Kloppel S, Abdulkadir A, Jack CR Jr, et al. Diagnostic neuroimaging across diseases. Neuroimage. 2012;61(2):457-463.
12. Orrù G, Pettersson-Yeo W, Marquand AF, et al. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review. Neurosci Biobehav Rev. 2012;36(4):1140-1152.
13. Braak H, Braak E. Neuropathological stageing of Alzheimer-Related changes. Acta Neuropathol. 1991;82(4):239-259.
14. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer?s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734-746.
15. Frisoni GB, Fox NC, Jack CR, et al. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67-77.
16. Fan Y, Batmanghelich N, Clark CM, et al. Spatial patterns of brain atrophy in MCI patients, identified via high-Dimensional pattern classification, predict subsequent cognitive decline. Neuroimage. 2008;39(4):1731-1743.
17. Gutman B, Wang Y, Morra J, et al. Disease classification with hippocampal shape invariants. Hippocampus. 2009;19(6):572-578.
18. Teipel SJ, Born C, Ewers M, et al. Multivariate deformation-Based analysis of brain atrophy to predict Alzheimer?s disease in mild cognitive impairment. Neuroimage. 2007;38(1):13-24.
19. Kloppel S, Stonnington CM, Barnes J, et al. Accuracy of dementia diagnosis: A direct comparison between radiologists and a computerized method. Brain. 2008;131(Pt 11):2969-2974.
20. Kloppel S, Stonnington CM, Chu C, et al. Automatic classification of MR scans in Alzheimer?s disease. Brain. 2008;131(Pt 3):681-689.
21. Graña M, Termenon M, Savio A, et al. Computer aided diagnosis system for Alzheimer disease using brain diffusion tensor imaging features selected by Pearson?s correlation. Neurosci Lett. 2011;502(3):225-229.
22. Fellows L, Bergman H, Wolfson C, et al. Can clinical data predict progression to dementia in amnestic mild cognitive impairment? Can J Neurol Sci. 2008;35(3):314-322.
23. Ferrarini L, Frisoni GB, Pievani M, et al. Morphological hippocampal markers for automated detection of Alzheimer?s disease and mild cognitive impairment converters in magnetic resonance images. J Alzheimers Dis. 2009;17(3):643-659.
24. Costafreda SG, Dinov ID, Tu Z, et al. Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage. 2011;56(1):212-219.
25. Misra C, Fan Y, Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-Term conversion to AD: Results from ADNI. Neuroimage. 2009;44(4):1415-1422.
26. O?Brien JT, Paling S, Barber R, et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology. 2001;56(10):1386-1388.
27. Burton EJ, Barber R, Mukaetova-Ladinska EB, et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer?s disease from dementia with Lewy bodies and vascular cognitive impairment: A prospective study with pathological verification of diagnosis. Brain. 2009;132(Pt 1):195-203.
28. Vemuri P, Simon G, Kantarci K, et al. Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND. Neuroimage. 2011;55(2):522-531.
29. Ford J, Farid H, Makedon F, et al. Patient classification of fMRI activation maps. Medical Image Computing and Computer-Assisted Intervention-MICCAI 2003, 6th International Conference, Montreal, QC; November 15-18, 2003; Proceedings. Springer; 2003. p 58-66.
30. Kontos D, Megalooikonomou V, Pokrajac D, et al. Extraction of discriminative functional MRI activation patterns and an application to Alzheimer?s disease. Medical Image Computing and Computer-Assisted Intervention-MICCAI 2004, 7th International Conference, Saint-Malo, France; September 26-29, 2004; Proceedings; Springer; 2004. p 727-735.
31. Stoeckel J, Ayache N, Malandain G, et al. Automatic classification of SPECT images of Alzheimer?s disease patients and control subjects. Lect Notes Comput Sci. 2004:654-662.
32. Fung G, Stoeckel J. SVM feature selection for classification of SPECT images of Alzheimer?s disease using spatial information. Knowl Inf Syst. 2007;11(2):243-258.
33. National Institute for Health and Clinical Excellence (NICE). NICE guidelines for dementia. London (GB): NICE; 2010.
34. Fitzgerald PB, Laird AR, Maller J, et al. A meta-Analytic study of changes in brain activation in depression. Hum Brain Mapp. 2008;29(6):683-695.
35. Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, et al. Brain volume abnormalities in major depressive disorder: A metaanalysis of magnetic resonance imaging studies. Hum Brain Mapp. 2009;30(11):3719-3735.
36. Fu CHY, Mourao-Miranda J, Costafreda SG, et al. Pattern classification of sad facial processing: Toward the development of neurobiological markers in depression. Biol Psychiatry. 2008;63(7):656-662.
37. Walsh ND, Williams SCR, Brammer MJ, et al. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry. 2007;62(11):1236-1243.
38. Marquand AF, Mourao-Miranda J, Brammer MJ, et al. Neuroanatomy of verbal working memory as a diagnostic biomarker for depression. Neuroreport. 2008;19(15):1507-1511.
39. Hahn T, Marquand AF, Ehlis A-C, et al. Integrating neurobiological markers of depression. Arch Gen Psychiatry. 2011;68(4):361-368.
40. Costafreda SG, Chu C, Ashburner J, et al. Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One. 2009;4(7):e6353.
41. Mwangi B, Matthews K, Steele JD. Prediction of illness severity in patients with major depression using structural MR brain scans. J Magn Reson Imaging. 2012;35(1):64-71.
42. Golland P, Grimson WEL, Shenton ME, et al. Detection and analysis of statistical differences in anatomical shape. Med Image Anal. 2005;9(1):69-86.
43. Yushkevich P, Joshi S, Pizer SM, et al. Feature selection for shapebased classification of biological objects. Inf Process Med Imaging. 2003;2732:114-125.
44. Ford J, Shen L, Makedon F, et al. A combined structural-Functional classification of schizophrenia using hippocampal volume plus fMRI activation. Second Joint EMBS-BMES Conference 2002-24th Annual International Conference of the Engineering in Medicine and Biology Society and Annual Fall Meeting of the Biomedical Engineering Society; October 23-26, 2002, Houston (TX). p 48-49.
45. Shen L. A surface-Based approach for classification of 3D neuroanatomic structures. Intell Data Anal. 2004;8(6):519-542.
46. Phillips LJ, Yung AR, Yuen HP, et al. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am J Med Genet. 2002;114(8):929-937.
47. Shinkareva SV, Ombao HC, Sutton BP, et al. Classification of functional brain images with a spatio-Temporal dissimilarity map. Neuroimage. 2006;33(1):63-71.
48. Koutsouleris N, Meisenzahl EM, Davatzikos C, et al. Use of neuroanatomical pattern classification to identify subjects in at-Risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry. 2009;66(7):700.
49. Calhoun VD, Maciejewski PK, Pearlson GD, et al. Temporal lobe and default hemodynamic brain modes discriminate between schizophrenia and bipolar disorder. Hum Brain Mapp. 2008;29(11):1265-1275.
50. Costafreda SG, Fu CH, Picchioni M, et al. Increased inferior frontal activation during word generation: A marker of genetic risk for schizophrenia but not bipolar disorder? Hum Brain Mapp. 2009;30(10):3287-3298.
51. Costafreda SG, Fu CHY, Picchioni M, et al. Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry. 2011;11:18.
52. Soriano-Mas C, Pujol J, Alonso P, et al. Identifying patients with obsessive-Compulsive disorder using whole-Brain anatomy. Neuroimage. 2007;35(3):1028-1037.
53. Ecker C, Marquand A, Mourão-Miranda J, et al. Describing the brain in autism in five dimensions-Magnetic resonance imaging-Assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J Neurosci. 2010;30(32):10612-10623.
54. Calhoun V, Pearlson G, Kiehl K. Automated classification of bipolar, schizophrenic, and healthy individuals via multiple spatial ICA functional brain modes. Machine Learning for Signal Processing, Proceedings of the 16th IEEE Signal Processing Society Workshop; September 6-8, 2006; Maynooth, Ireland. p 371-376.
55. Zhang L, Samaras D, Tomasi D, et al. Machine Learning for Clinical Diagnosis from Functional Magnetic Resonance Imaging. IEEE Computer Society Conference on Computer Vision and Pattern Recognition; June 20-26, 2005; San Diego, CA. p 1211-1217.
56. Buchsbaum MS, Joseph W, Siegel BV, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 1997;41(1):15-22.
57. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: A potential predictor of treatment response. Neuroreport. 1997;8(4):1057-1061.
58. Fu CH, Williams SC, Cleare AJ, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-Related functional magnetic resonance imaging study. Arch Gen Psychiatry. 2004;61(9):877-889.
59. Fu CHY, Williams SCR, Cleare AJ, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry. 2008;64(6):505-512.
60. Fu CH, Steiner H, Costafreda SG. Predictive neural biomarkers of clinical response in depression: A meta-Analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis. 2013;52:75-83.
61. Gong Q, Wu Q, Scarpazza C, et al. Prognostic prediction of therapeutic response in depression using high-Field MR imaging. Neuroimage. 2011;55:1497-1503.
62. Costafreda SG, Khanna A, Mourao-Miranda J, et al. Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport. 2009;20(7):637-641.
63. Khodayari-Rostamabad A, Hasey GM, MacCrimmon DJ, et al. A pilot study to determine whether machine learning methodologies using pre-Treatment electroencephalography can predict the symptomatic response to clozapine therapy. Clin Neurophysiol. 2010;121(12):1998-2006.
64. Rutjes A, Reitsma J, Coomarasamy A, et al. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess. 2007;50(11):iii, ix-51.
65. Regier DA, Narrow WE, Kuhl EA, et al. The conceptual development of DSM-V. Am J Psychiatry. 2009;166(6):645-650.
66. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry. 1970;126(7):983-987.
67. Kendler KS. Toward a scientific psychiatric nosology. Strengths and limitations. Arch Gen Psychiatry. 1990;47(10):969-973.
68. Nouretdinov I, Costafreda SG, Gammerman A, et al. Machine learning classification with confidence: Application of transductive conformal predictors to MRI-Based diagnostic and prognostic markers in depression. Neuroimage. 2011;56(2):809-813; Epub 2010 May 17.
69. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, et al. Assessing the value of diagnostic tests: A framework for designing and evaluating trials. BMJ. 2012;344:e686.
70. Jain A, Duin R, Mao J. Statistical pattern recognition: A review. IEEE Trans Pattern Anal Mach Intell. 2000;22(1):4-37.
71. Higdon R, Foster NL, Koeppe RA, et al. A comparison of classification methods for differentiating fronto-Temporal dementia from Alzheimer?s disease using FDG-PET imaging. Stat Med. 2004;23(2):315-326.
72. Huppertz HJ, Kröll-Seger J, Danek A, et al. Automatic striatal volumetry allows for identification of patients with choreaacanthocytosis at single subject level. J Neural Transm. 2008;115(10):1393-1400.
73. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer?s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734-746.
74. Pepe MS, Feng Z, Janes H, et al. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design. J Natl Cancer Inst. 2008;100(20):1432-1438.
75. Henley SM, Ridgway GR, Scahill RI, et al. Pitfalls in the use of voxel-Based morphometry as a biomarker: Examples from Huntington disease. Am J Neuroradiol. 2010;31(4):711-719.
76. Detre GJ, Polyn SM, Moore CD, et al. The Multi-Voxel Pattern Analysis (MVPA) toolbox. Poster presented at the Annual Meeting of the Organization for Human Brain Mapping. 2006 Florence (IT). Available from: Http://www.csbmb. princeton.edu/mvpa.
77. Hanke M, Halchenko YO, Sederberg PB, et al. PyMVPA: A Python toolbox for multivariate pattern analysis of fMRI data. Neuroinformatics. 2009;7(1):37-53. Available from: Http://www.pymvpa.org.
78. Vapnik V. The nature of statistical learning theory. New York (NY): Springer-Verlag; 1995.
79. Chang RF, Wu WJ, Moon WK, et al. Support vector machines for diagnosis of breast tumors on US images. Acad Radiol. 2003;10(2):189-197.
80. Lee Y, Mangasarian O, Wolberg W. Breast cancer survival and chemotherapy: A support vector machine analysis. Discrete mathematical problems with medical applications: DIMACS Workshop, December 8-10, 1999 [book]. [place of publication unknown]: American Mathematical Society; 2000. p 1-10.
81. Furey TS, Cristianini N, Duffy N, et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics. 2000;16(10):906-914.
82. Wang Y, Fan Y, Bhatt P, et al. High-Dimensional pattern regression using machine learning: From medical images to continuous clinical variables. Neuroimage. 2010;50(4):1519-1535.
83. Davatzikos C, Shen D, Gur RC, et al. Whole-Brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry. 2005;62(11):1218-1227.